- Home
- RMNI vs ARCT Comparison
RMNI vs ARCT Comparison
Compare RMNI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMNI
- ARCT
- Stock Information
- Founded
- RMNI 2005
- ARCT 2013
- Country
- RMNI United States
- ARCT United States
- Employees
- RMNI N/A
- ARCT N/A
- Industry
- RMNI Business Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- RMNI Consumer Discretionary
- ARCT Health Care
- Exchange
- RMNI Nasdaq
- ARCT Nasdaq
- Market Cap
- RMNI 368.8M
- ARCT 298.3M
- IPO Year
- RMNI N/A
- ARCT N/A
- Fundamental
- Price
- RMNI $3.57
- ARCT $11.86
- Analyst Decision
- RMNI Buy
- ARCT Strong Buy
- Analyst Count
- RMNI 2
- ARCT 7
- Target Price
- RMNI $6.00
- ARCT $57.40
- AVG Volume (30 Days)
- RMNI 230.8K
- ARCT 410.5K
- Earning Date
- RMNI 05-01-2025
- ARCT 05-12-2025
- Dividend Yield
- RMNI N/A
- ARCT N/A
- EPS Growth
- RMNI N/A
- ARCT N/A
- EPS
- RMNI N/A
- ARCT N/A
- Revenue
- RMNI $426,212,000.00
- ARCT $143,680,000.00
- Revenue This Year
- RMNI $0.74
- ARCT N/A
- Revenue Next Year
- RMNI $4.46
- ARCT $44.93
- P/E Ratio
- RMNI N/A
- ARCT N/A
- Revenue Growth
- RMNI N/A
- ARCT 15.38
- 52 Week Low
- RMNI $1.53
- ARCT $8.04
- 52 Week High
- RMNI $4.15
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- RMNI 58.47
- ARCT 50.74
- Support Level
- RMNI $3.22
- ARCT $10.70
- Resistance Level
- RMNI $3.45
- ARCT $13.10
- Average True Range (ATR)
- RMNI 0.21
- ARCT 0.89
- MACD
- RMNI 0.02
- ARCT -0.01
- Stochastic Oscillator
- RMNI 90.38
- ARCT 35.69
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.